Free Trial
NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

Bioceres Crop Solutions logo
$3.61 -0.14 (-3.73%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.66 +0.05 (+1.50%)
As of 07/18/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Key Stats

Today's Range
$3.61
$3.90
50-Day Range
$3.61
$5.16
52-Week Range
$3.51
$11.41
Volume
86,494 shs
Average Volume
184,247 shs
Market Capitalization
$226.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.38
Consensus Rating
Buy

Company Overview

Bioceres Crop Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

BIOX MarketRank™: 

Bioceres Crop Solutions scored higher than 45% of companies evaluated by MarketBeat, and ranked 105th out of 152 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bioceres Crop Solutions has only been the subject of 1 research reports in the past 90 days.

  • Read more about Bioceres Crop Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Bioceres Crop Solutions are expected to grow in the coming year, from ($0.05) to $0.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bioceres Crop Solutions is -25.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bioceres Crop Solutions is -25.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bioceres Crop Solutions has a PEG Ratio of 1.60. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Bioceres Crop Solutions has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bioceres Crop Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    1.92% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently increased by 3.47%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Bioceres Crop Solutions does not currently pay a dividend.

  • Dividend Growth

    Bioceres Crop Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.92% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently increased by 3.47%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Bioceres Crop Solutions has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Bioceres Crop Solutions this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for BIOX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Bioceres Crop Solutions to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bioceres Crop Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.31% of the stock of Bioceres Crop Solutions is held by insiders.

  • Percentage Held by Institutions

    Only 17.68% of the stock of Bioceres Crop Solutions is held by institutions.

  • Read more about Bioceres Crop Solutions' insider trading history.
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

BIOX Stock News Headlines

BIOX Bioceres Crop Solutions Corp. - Seeking Alpha
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

BIOX Stock Analysis - Frequently Asked Questions

Bioceres Crop Solutions' stock was trading at $6.08 on January 1st, 2025. Since then, BIOX shares have decreased by 40.6% and is now trading at $3.61.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced its quarterly earnings results on Wednesday, May, 21st. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.08. The company earned $59.60 million during the quarter, compared to analyst estimates of $61.80 million. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative trailing twelve-month return on equity of 2.37%.
Read the conference call transcript
.

Bioceres Crop Solutions (BIOX) raised $130 million in an IPO on Wednesday, February 7th 2018. The company issued 11,800,000 shares at $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.

Top institutional investors of Bioceres Crop Solutions include Avanza Fonder AB (0.04%).

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Builders FirstSource (BLDR) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/21/2025
Today
7/19/2025
Next Earnings (Estimated)
9/08/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
AGRI OPERATIONS
Sub-Industry
Trading
Current Symbol
NASDAQ:BIOX
CIK
1769484
Fax
N/A
Employees
500
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$6.00
Potential Upside/Downside
+132.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.6
Net Income
$3.24 million
Net Margins
-2.14%
Pretax Margin
-4.90%
Return on Equity
-2.37%
Return on Assets
-0.99%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
1.02
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$464.80 million
Price / Sales
0.49
Cash Flow
$0.38 per share
Price / Cash Flow
9.62
Book Value
$5.56 per share
Price / Book
0.65

Miscellaneous

Outstanding Shares
62,710,000
Free Float
61,262,000
Market Cap
$226.38 million
Optionable
Optionable
Beta
0.41
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:BIOX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners